Welcome to the 2nd Integrin-Targeted Drug Development Summit
This is an exciting opportunity to join 80+ experts and be part of the definitive industry forum for drug developers tackling the issues of safety, selectivity, and specificity in integrin drug development, including Autoimmune, Ophthalmology, and IO perspectives to inform your R&D decisions and leverage the lessons learned over the past 20 years to enhance your bed to bedside progression.
Participate in the 2nd Integrin-Targeted Drug Development Summit to keep up to date with the latest integrin research and:
This cross-disciplinary program featuring keynote talks from clinical decision-makers in large pharma, biotech, and academia, will give insights into the full therapeutic opportunity of integrins.
View our full event guide to see our complete speaker line-up, latest agenda, and attending audience.